• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX INC. AFX2; AFX2 BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX INC. AFX2; AFX2 BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA28-90/I20-30
Device Problems Decoupling (1145); Material Separation (1562); Unintended Movement (3026); Separation Problem (4043)
Patient Problem Failure of Implant (1924)
Event Date 01/02/2019
Event Type  Injury  
Manufacturer Narrative
The device will not be returned for evaluation as it remains in the patient.A follow-up report will be submitted upon completion of investigation.
 
Event Description
An afx2 bifurcated stent graft, an afx suprarenal stent graft extension and an ovation ix extender were implanted to treat an abdominal aortic aneurysm.Approximately 3.5 years post initial procedure the patient was in a traumatic car accident.Post car accident stent separation and a type 3a endoleak were identified.It is probable that the seatbelt caused the device failure.The patient underwent successful re-intervention with excellent results and is doing great.
 
Manufacturer Narrative
The manufacturing lot evaluation confirmed all devices met specifications prior to release.The device was not returned as the device remains implanted therefore no evaluation was completed.At the completion of the clinical assessment, clinical was able to find substantial evidence to support the following events of a type 3a endoleak.Procedure related harms, device, user, procedure or anatomy relatedness of this complaint could not be determined.The patient was in a motor vehicle accident and this may have contributed to this event.No additional investigation of this reported event is planned however if additional information pertinent to the incident is obtained, a follow-up report will be submitted.Endologix will continue to monitor this complaint and similar complaints in the event further investigation is needed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Type of Device
AFX2 BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX INC.
2 musick
irvine CA 92618
MDR Report Key8289133
MDR Text Key134488535
Report Number2031527-2019-00066
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009014559
UDI-Public(01)00818009014559(17)170314
Combination Product (y/n)N
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Recall
Type of Report Initial,Followup
Report Date 01/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/14/2017
Device Model NumberBEA28-90/I20-30
Device Lot Number1355102013
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/03/2019
Initial Date FDA Received01/30/2019
Supplement Dates Manufacturer Received02/12/2019
Supplement Dates FDA Received03/30/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-1049-2017
Patient Sequence Number1
Treatment
AFX VELA SUPRARENAL (LN 1472869013); OVATION IX EXTENDER (LN FS020416-24); AFX VELA SUPRARENAL (LN 1472869013); OVATION IX EXTENDER (LN FS020416-24)
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-